Corbus Pharmaceuticals Holdings Inc

NASDAQ:CRBP   4:00:00 PM EDT
0.12
-0.01 (-4.42%)
7:56:27 PM EDT: $0.13 +0.01 (+4.46%)
Earnings Announcements

Corbus Pharmaceuticals Reports Third Quarter Results

Published: 11/08/2022 15:41 GMT
Corbus Pharmaceuticals Holdings Inc (CRBP) - Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Corbus Pharmaceuticals Holdings Inc- Cash and Investments on Hand of $67 Million Funds Operations Through the Second Quarter of 2024.
Corbus Pharmaceuticals Holdings Inc- Ind Submission for Crb-601 is on Track for Mid-2023.
Corbus Pharmaceuticals Holdings Inc - Qtrly Loss per Share $0.07.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.